UK Patients to Gain Speedier Access to New Medical Tech
The UK government has launched the Innovative Development Access Pathway (IDAP), a new initiative aimed at expediting patient access to innovative medical technologies. With £10 million in government funding, the IDAP will provide innovators and manufacturers with multi-partner support and targeted scientific advice.
Supporting Rapid Development of Innovative Technologies
The IDAP is a significant step forward in implementing the Medical Technology Strategy, aiming to ensure the adoption of specialty innovative medical technology into the NHS. David Lawson, Director of Medical Technology at the Department of Health and Social Care, emphasizes the importance of this initiative in benefiting patient outcomes and showcasing the regulatory and guidance bodies supporting the pathway.
Expediting Access for Patients
Dr Susan Myles, Director of Health Technology Wales, expresses pride in being part of this ground-breaking project that aims to speed up access to innovative technologies for patients across the country. The IDAP provides an exciting opportunity for innovators to apply and receive support throughout the pathway, ensuring the successful adoption of their technologies.
Accelerating Delivery of Cutting-Edge Medical Technologies
Dr Marc Bailey, MHRA Chief Science and Innovation Officer, highlights the IDAP launch as an exciting step in delivering cutting-edge medical technologies safely to patients in the UK. The pilot phase will provide valuable insights to shape the future direction of the pathway. Medical technology innovators are encouraged to submit their applications and benefit from the combined support service.
Focusing on Value and Unmet Needs
Jeanette Kusel, Director of NICE Scientific Advice, emphasizes the focus on addressing unmet needs in the healthcare system and properly demonstrating the value of innovations. The IDAP offers developers of game-changing health technologies the opportunity to access expertise from both regulators and health technology appraisers, ensuring their innovations have a meaningful impact.
With the launch of the IDAP, UK patients can look forward to faster access to innovative medical technologies that address their clinical needs. The pathway’s multi-partner support and targeted scientific advice will ensure the safety, quality, and effectiveness of these technologies while expediting their introduction into the NHS.
